Form 4 · Filed Feb 4, 2026, 12:00 PM UTC
KNSA/Kiniksa Pharmaceuticals International, plc
Quart Barry D — director
Pro feature
Read the AI thesis behind every Form 4 — only on Pro and Premium
Free accounts see filings 24 hours late and the thesis is hidden until then. Upgrade to read every Form 4 the moment it hits EDGAR, with a Sonnet-4.6 (or Opus-4.7 on flagged buys) thesis attached.
Free
FreeBrowse the last 30 days of insider filings. Weekly digest by email.
- · Last 30 days of filings (list view)
- · Conviction score badge on each filing
- · Insider profiles & edge scores
Pro
$15/moAI thesis on every filing + watchlist email alerts.
- · Full AI thesis on every Form 4 (Sonnet 4.6)
- · Full filing history (no 30-day cap)
- · Unlimited ticker watchlists
Premium
$49/moOpus 4.7 deep theses + SMS alerts + cluster-buy detection.
- · Everything in Pro
- · Opus-grade thesis on flagged buys
- · SMS alerts for highest-conviction filings
Transactions
9 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 4, 2026 | M | other | 2,602 | $0 | — | 2,800 |
| Feb 4, 2026 | M | other | 2,602 | $15 | $40,253 | 15,148 |
| Feb 4, 2026 | S | sell | 2,602 | $45 | $117,142 | 12,546 |
| Feb 3, 2026 | S | sell | 12,528 | $45 | $567,143 | 12,546 |
| Feb 3, 2026 | M | other | 12,528 | $0 | — | 5,402 |
| Feb 3, 2026 | M | other | 12,528 | $15 | $193,808 | 25,074 |
| Feb 2, 2026 | M | other | 830 | $15 | $12,840 | 13,376 |
| Feb 2, 2026 | M | other | 830 | $0 | — | 17,930 |
| Feb 2, 2026 | S | sell | 830 | $45 | $37,350 | 12,546 |
Source: SEC EDGAR raw filing ↗ · Accession 0001384243-26-000002